Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPz Cussons Regulatory News (PZC)

Share Price Information for Pz Cussons (PZC)

Share Price is delayed by 15 minutes
Get Live Data
87.40    2.10 (2.46%)
Bid:
87.00
Ask:
88.90
Spread: 1.90 (2.184%)
Market Cap: £367.39m
PZC Live PriceLast checked at - London Stock Exchange

Intraday Pz Cussons Share Chart

Trading Statement

9 Jun 2016 07:00

RNS Number : 6604A
PZ CUSSONS PLC
09 June 2016
Β 

9 June 2016

Β PZ Cussons Plc

(the "Group")

Β 

Trading Update

Β 

PZ Cussons Plc, a leading consumer products group, today issues the following trading update for the year ended 31 May 2016.

Β 

Overview of financial performance and position

Β 

The board is pleased to announce that the performance of the Group for the year ended 31 May 2016 has been in line with expectations with performance in Europe and Asia offsetting more difficult trading conditions in Africa.

The financial position of the Group remains strong with cash generation also in line with expectations.

Β 

Trading Update

Β 

Europe

Β 

In the UK washing and bathing division, all brands have performed strongly driven by a continuous programme of renovation and innovation. The Imperial Leather portfolio has been extended with a new range of Sweets and Fruits products for bath and shower. The new range of shower and bath products under the Carex brand has performed well in addition to good growth across the core range of handwash products. Original Source has also performed well with new fragrances launched across its range of shower, handwash and body care products.

Β 

In the beauty division, St Tropez has seen excellent growth its key markets of UK, US and Australia. The gradual tan in shower lotion launched last year has been particularly successful and the range has recently been extended with a darker variant. Further product launches have also taken place across the Sanctuary, Charles Worthington and Fudge brands.

Β 

Performance in the smaller markets of Poland and Greece has been in line with expectations.

Β 

Asia

Β 

In Australia, good performance across Personal Care, Beauty and Food & Nutrition has offset more difficult trading conditions in the Home Care category. Both five:am and Rafferty's Garden have extended their product portfolios during the year with Rafferty's Garden launching into chilled products and continuing its overseas expansion into selected geographies.

Β 

Indonesia has seen another year of good revenue growth with the entire baby range being completely re-launched in the second half of the year. Further renovation has also taken place across Imperial Leather, Carex and Original Source.

Β 

Overall performance in the smaller markets of Thailand and the Middle East has been in line with expectations.

Β 

Africa

Β 

In Nigeria, all business units are selling relatively well despite a challenging macro environment where consumers are being affected by inflationary pressures. We continue to have market leading brand shares across Personal Care, Home Care, Electricals and Food & Nutrition and product offerings at all price points. In addition, our nationwide distribution and heritage in Nigeria are serving us well in these difficult trading conditions.

Β 

There continues to be low levels of dollar liquidity in the economy with an additional cost of funding naira from the secondary market. Our focus is on securing materials for the key selling product lines, developing local sourcing to reduce our overall dollar requirements and ensuring relative pricing remains competitive.

Β 

Overall performance in the smaller markets of Ghana and Kenya has been in line with expectations.

Β 

Exceptional Charge

Β 

An exceptional charge of circa Β£17m is expected in relation to settling a brought forward dollar liability in Nigeria in the secondary market. The charge will be accounted for as it is realised with circa Β£7m being taken in the year to 31 May 2016.

Β 

Outlook

Β 

Performance in Europe and Asia is expected to be strong driven by the continuing brand renovation and innovation programme underpinned by strong cost control.

Β 

In Nigeria, which represents approximately 25% of group profits, trading conditions are expected to continue to be challenging, with a range of potential outcomes for the new financial year dependent on the translational and transactional impacts of any movement in the naira exchange rate. The Group remains well placed to benefit from its position in Nigeria once growth returns to the market.

Β 

The Group's balance sheet remains strong and well placed to pursue new opportunities for growth as they arise.

Β 

Final results

Β 

Final results for the year ended 31 May 2016 will be announced on Tuesday 26 July 2016.

Β 

An analysts' presentation will be given at 9:30am on that day. This will be held at the offices of Instinctif Partners, 65 Gresham Street, London, EC2V 7NQ. Dial in details will be available immediately following the final results announcement.

Β 

- ENDS -

Β 

For further information contact:

Β 

PZ Cussons Plc Tel: 0161 435 1236

Brandon Leigh - Chief Financial Officer

Β 

Instinctif Tel: 020 7457 2020

Tim Linacre

Guy Scarborough

Β 

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
TSTUWRNRNVANRAR
Date   Source Headline
1st Apr 201011:21 amRNSDirector/PDMR Shareholding
25th Mar 20104:51 pmRNSDirector/PDMR Shareholding
19th Feb 201010:42 amRNSDirector/PDMR Shareholding
3rd Feb 20106:00 pmRNSDirector/PDMR Shareholding
26th Jan 20107:00 amRNSHalf Yearly Report
9th Dec 20097:00 amRNSTrading Update
26th Nov 20097:00 amRNSAppointment of Richard Harvey as Chairman-elect
20th Oct 20095:15 pmRNSHolding(s) in Company
19th Oct 20094:27 pmRNSDirector/PDMR Shareholding
6th Oct 20095:57 pmRNSResult of AGM
5th Oct 20097:00 amRNSInterim Management Statement
18th Sep 20097:00 amRNSAnnual Information Update
3rd Sep 20093:15 pmRNSDirector/PDMR Shareholding
25th Aug 20098:00 amRNSAnnual Financial Report
17th Aug 20097:00 amRNSDirector/PDMR Shareholding
31st Jul 20091:17 pmRNSDirector/PDMR Shareholding
30th Jul 20096:00 pmRNSDirector/PDMR Shareholding
28th Jul 20097:00 amRNSFinal Results
9th Jul 20094:35 pmRNSPrice Monitoring Extension
10th Jun 20097:00 amRNSTrading Update
2nd Jun 20099:11 amRNSNotice of Trading Update and Preliminary Results
8th Apr 20097:00 amRNSInterim Management Statement
13th Feb 20094:32 pmRNSDirector/PDMR Shareholding
27th Jan 20097:00 amRNSHalf Yearly Report
9th Dec 20087:00 amRNSTrading Statement
27th Nov 20084:36 pmRNSPrice Monitoring Extension
12th Nov 20082:19 pmRNSDirector/PDMR Shareholding
3rd Nov 200812:07 pmRNSDirector/PDMR Shareholding
6th Oct 20087:00 amRNSNotice of Trading Update
2nd Oct 20084:47 pmRNSDirector/PDMR Shareholding
29th Sep 20087:00 amRNSInterim Management Statement
18th Sep 20087:00 amRNSAppointment of Joint Broker
17th Sep 20087:00 amRNSAnnual Information Update
29th Jul 20087:00 amRNSFinal Results
5th Jun 20087:00 amRNSTrading Update
14th Apr 200812:30 pmRNSDirector/PDMR Shareholding
8th Apr 20087:00 amRNSInterim Management Statement
11th Mar 20089:05 amRNSPurchased Shares
29th Jan 20087:01 amRNSAcquisition
29th Jan 20087:01 amRNSInterim Results
3rd Jan 200810:35 amRNSDirector Declaration
6th Dec 20077:00 amRNSTrading Statement
19th Nov 20072:04 pmRNSDirectorate Change
16th Oct 20079:33 amRNSDirector/PDMR Shareholding
12th Oct 200710:58 amRNSDirector/PDMR Shareholding
10th Oct 20072:59 pmRNSDirector/PDMR Shareholding
24th Sep 20077:01 amRNSInterim Management Statement
20th Sep 20077:01 amRNSAnnual Information Update
8th Aug 20074:05 pmRNSDirector/PDMR Shareholding
2nd Aug 20076:07 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.